Syncope is a common and disabling condition that is associated with an increased risk of morbidity and mortality and remains difficult to diagnose.1 Medical literature reports that a diagnosis is possible in up to 90% of patients with syncope using an implantable monitor.2
The SJM Confirm ICM is an integrated system consisting of the implantable device used for automatic-triggered event storage, the handheld, external device called the Patient Activator used for patient-triggered event storage, and the Merlin® Patient Care System, which provides communication, data retrieval and programming capabilities.
- Small size – at 6.5 cc – the smallest ICM on the market
- Excellent longevity – three years
- Subcutaneous electrodes for simplified procedure
- Proven SenseAbility® technology designed for accurate sensing over a wide range of signals
- Detection inhibitors for noise response and activity response
- Compatibility with Merlin Patient Care System (PCS)
- Patient-triggered activation option for EGM storage
- Additional programming options – tachycardia, bradycardia, asystole
- 48 minutes of stored electrograms (147 episodes)
- Data storage options for flexibility
- Comprehensive diagnostic data to assist in patient management
- Transtelephonic monitoring for timely and accurate data transmission
2 Krahn AD, Klein GJ, Yee R et al. Use of an extended monitoring strategy in patients with problematic syncope. Circulation 1999; 99: 406-10.